New shareholders probably don’t understand the phase 2b data and how POWERFUL it was.......Brilacidin in phase 2 under POLYMEDIX almost failed because of the high dosing. In stepped IPIX to adjust the dosing and went to single dosing and less and the SAEs went away and the drug was extremely effective. Comparable to daptomycin which was atleast 7 days dosing and B ROCKED the trial! Dapto and cubist were bought for like 8 billion at the time. B is a rockstar.
News 
Market Data 
Discover 
